Teva share price at 6-year high after trial results
The market cap of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA rose by $5 billion yesterday, after the ...
Tag: Trial
FDA approves Revelation Biosciences’ drug trial for CKD By Investing.com
SAN DIEGO - Revelation Biosciences Inc. (NASDAQ: REVB), a clinical-stage life sciences firm with a market capitalization of $3.26 million, ...
Research Grid raises $6.48M to automate clinical trial admin | TechCrunch
Amber Hill spent 14 years as a medical researcher. She didn’t thoughts the work, however there was one factor she ...
Tornado Cash Developer Roman Storm’s Trial Delayed Until April
Along with probably hurting Storm’s protection, Klein’s letter to the court docket prompt that Decide Failla’s ruling could have contravened ...
Novartis oral Fabhalta ® (iptacopan) sustained clinically meaningful results at one year in Phase III C3 glomerulopathy (C3G) trial By Investing.com
New APPEAR-C3G knowledge present Fabhalta sustained proteinuria discount at 12 months1Upon Fabhalta initiation, enchancment noticed in estimated glomerular filtration price ...
Sean ‘Diddy’ Combs’ sex trafficking trial set for May By Reuters
By Luc Cohen NEW YORK (Reuters) - Sean "Diddy" Combs will stand trial on federal intercourse trafficking and racketeering costs ...
Kraken Seeks Jury Trial in SEC Lawsuit, Presents Defense Arguments
The SEC sued Kraken within the Northern District of California final November asking the courtroom to completely enjoin the alternate ...
Sarah Palin wins new trial in New York Times defamation case By Reuters
By Jonathan Stempel NEW YORK (Reuters) -Sarah Palin on Wednesday gained her bid for a brand new trial in opposition ...
Alterity reports positive Phase 2 trial interim data By Investing.com
Alterity Therapeutics Restricted, a pharmaceutical firm specializing within the improvement of remedies for neurodegenerative ailments, introduced optimistic interim knowledge from ...
™E Pharma Announces Oral Presentation of NOX-A12 GLORIA Phase 1/2 Trial in Glioblastoma at ESMO Congress 2024 By Investing.com
BERLIN--(BUSINESS WIRE)--™E Pharma N.V. (Euronext Progress Paris: AL™E), a clinical-stage biotechnology firm targeted on growing novel therapies for remedy of ...